VACCINE INSIGHTS

mRNA: harnessing the benefits, addressing the challenges

September 2022
mRNA: harnessing the benefits, addressing the challenges

Expert Insight

A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

S Daniel, Z Kis, C Kontoravdi et al.
22 September 2022
Read

Innovator Insight

Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness

Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness

Tracy Humphries
10 November 2022
Read

Commentary

mRNA Vaccines: a growing and complex IP landscape

mRNA Vaccines: a growing and complex IP landscape

Robert Burrows, Ellen Lambrix
4 September 2022
Read

FastFacts

End-to-end solutions for mRNA development and manufacturing

End-to-end solutions for mRNA development and manufacturing

Susana Domingues-Vallon
21 November 2022
Read

Interview

RNA vaccine production 4.0

RNA vaccine production 4.0

Zoltan Kis
4 September 2022
Read
RNA pioneer Ingmar Hoerr: from entrepreneur to philanthropist

RNA pioneer Ingmar Hoerr: from entrepreneur to philanthropist

Ingmar Hoerr
24 August 2022
Read

Webinars

Process and analytical insights for GMP manufacturing of mRNA lipid nanoparticles

Process and analytical insights for GMP manufacturing of mRNA lipid nanoparticles

E Cameau, P Zhang, S Ip et al.
28 September 2022
Watch